During our 100+ years as a full-service, growth investment bank, we‘ve empowered our clients’ success by delivering a depth and breadth of insights across a broad range of sectors and capabilities.
Ahead of the Curve®
Dec 13, 2023
A New Chapter In Biosecurity: Are We Prepared?
Read More >
Ahead of the Curve®
Oct 3, 2023
Back to School: Grading FDA Divisions on Regulatory Flexibility
Read More >
Ahead of the Curve®
Sep 19, 2023
Investors Guide to Immuno-Oncology
Read More >
Ahead of the Curve®
Jun 9, 2023
5th Annual Investor Primer on Antibody Drug Conjugates
Read More >
May 5, 2023
Best ESG Investment Ideas for 2023
Read More >
Ahead of the Curve®
Apr 25, 2023
A Primer On The Next Generation Of Radiopharmaceuticals
Read More >
Ahead of the Curve®
Mar 13, 2023
The Biotech Executive: Bold, Tenacious, And Accountable
Read More >
Ahead of the Curve®
Jan 27, 2023
The Price Is (Not) Right: Discounts, 340B, Access, And IRA
Read More >
Video
Ahead of the Curve®
Oct 4, 2022
Pandemic Preparedness: Roadmap to a More Prepared Future
Read More >
Video
Ahead of the Curve®
Sep 27, 2022
Trials & Triumphs of the FDA: What Matters? Where are We?
Read More >
Video
Ahead of the Curve®
Sep 26, 2022
The Consumerization of Wellness
Read More >
Ahead of the Curve®
Jun 9, 2022
Forward Progress: ESG Primer on Clinical Trial Diversity
Read More >
In order to optimize our website for you and to be able to continuously improve it, we use cookies. By continuing to use the website, you agree to the use of cookies. Further information on cookies can be found in our Privacy Policy.